N6-Methyladenosine RNA Methylation: A Key Regulator in Male Reproductive Disorders and Urological Cancers

This publication has 154 references indexed in Scilit:

• circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma
  Clinical and Translational Medicine, 2023
• Advancing Patient-Centered Outcomes and Equity in Clinical Trials for BCG-Unresponsive Nonmuscle Invasive Bladder Cancer
  JAMA Oncology, 2023
• Immunotherapy in the Treatment of Localized Genitourinary Cancers
  JAMA Oncology, 2023
• PD1^hi CD200^hi CD4⁺ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial–mesenchymal transition in bladder cancer
  Clinical and Translational Medicine, 2023
• A Dual‐Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis
  Advanced Materials, 2023
• METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
  Cancer Communications, 2023
• Characterisation of a novel transcript LNPPS acting as tumour suppressor in bladder cancer via PDCD5‐mediated p53 degradation blockage
  Clinical and Translational Medicine, 2022
• ZNF677 suppresses renal cell carcinoma progression through N6‐methyladenosine and transcriptional repression of CDKN3
  Clinical and Translational Medicine, 2022
• Downregulation of m⁶A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness
  Molecular Oncology, 2022
• New insights into the interplay between long non‐coding RNAs and RNA‐binding proteins in cancer
  Cancer Communications, 2022